BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10844056)

  • 1. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy.
    Nguyen QD; Kempen JH; Bolton SG; Dunn JP; Jabs DA
    Am J Ophthalmol; 2000 May; 129(5):634-9. PubMed ID: 10844056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis.
    Zegans ME; Walton RC; Holland GN; O'Donnell JJ; Jacobson MA; Margolis TP
    Am J Ophthalmol; 1998 Mar; 125(3):292-300. PubMed ID: 9512145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy.
    Robinson MR; Reed G; Csaky KG; Polis MA; Whitcup SM
    Am J Ophthalmol; 2000 Jul; 130(1):49-56. PubMed ID: 11004259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune recovery uveitis in AIDS patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy in Venezuela.
    Arevalo JF; Mendoza AJ; Ferretti Y
    Retina; 2003 Aug; 23(4):495-502. PubMed ID: 12972761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis.
    Song MK; Azen SP; Buley A; Torriani F; Cheng L; Chaidhawangul S; Ozerdem U; Scholz B; Freeman WR
    Am J Ophthalmol; 2003 Oct; 136(4):696-702. PubMed ID: 14516810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis.
    Kempen JH; Min YI; Freeman WR; Holland GN; Friedberg DN; Dieterich DT; Jabs DA;
    Ophthalmology; 2006 Apr; 113(4):684-94. PubMed ID: 16581429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes.
    Karavellas MP; Azen SP; MacDonald JC; Shufelt CL; Lowder CY; Plummer DJ; Glasgow B; Torriani FJ; Freeman WR
    Retina; 2001; 21(1):1-9. PubMed ID: 11217922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome.
    Karavellas MP; Lowder CY; Macdonald C; Avila CP; Freeman WR
    Arch Ophthalmol; 1998 Feb; 116(2):169-75. PubMed ID: 9488268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Jabs DA; Van Natta ML; Kempen JH; Reed Pavan P; Lim JI; Murphy RL; Hubbard LD
    Am J Ophthalmol; 2002 Jan; 133(1):48-61. PubMed ID: 11755839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Whitcup SM
    JAMA; 2000 Feb; 283(5):653-7. PubMed ID: 10665706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune recovery uveitis.
    Kuppermann BD; Holland GN
    Am J Ophthalmol; 2000 Jul; 130(1):103-6. PubMed ID: 11004267
    [No Abstract]   [Full Text] [Related]  

  • 12. Optic nerve head neovascularization in a patient with inactive cytomegalovirus retinitis and immune recovery.
    Sanislo SR; Lowder CY; Kaiser PK
    Am J Ophthalmol; 1998 Aug; 126(2):318-20. PubMed ID: 9727534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cystoid macular edema and cytomegalovirus retinitis in AIDS patients treated with antiretroviral triple therapy].
    Badelon I; Gohier P; Chaine G
    J Fr Ophtalmol; 1999 Dec; 22(10):1034-41. PubMed ID: 10617840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis.
    Holbrook JT; Colvin R; van Natta ML; Thorne JE; Bardsley M; Jabs DA;
    Am J Ophthalmol; 2011 Oct; 152(4):628-637.e1. PubMed ID: 21742304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower incidence and severity of cytomegalovirus-associated immune recovery uveitis in HIV-infected patients with delayed highly active antiretroviral therapy.
    Ortega-Larrocea G; Espinosa E; Reyes-TerĂ¡n G
    AIDS; 2005 Apr; 19(7):735-8. PubMed ID: 15821403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes.
    Jabs DA; Ahuja A; Van Natta M; Lyon A; Srivastava S; Gangaputra S;
    Ophthalmology; 2010 Nov; 117(11):2152-61.e1-2. PubMed ID: 20673591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraocular viral and immune pathogenesis of immune recovery uveitis in patients with healed cytomegalovirus retinitis.
    Schrier RD; Song MK; Smith IL; Karavellas MP; Bartsch DU; Torriani FJ; Garcia CR; Freeman WR
    Retina; 2006 Feb; 26(2):165-9. PubMed ID: 16467672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus retinitis and the acquired immunodeficiency syndrome--bench to bedside: LXVII Edward Jackson Memorial Lecture.
    Jabs DA
    Am J Ophthalmol; 2011 Feb; 151(2):198-216.e1. PubMed ID: 21168815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of treatment of macular complications in eyes with immune recovery uveitis using a graded treatment approach.
    El-Bradey MH; Cheng L; Song MK; Torriani FJ; Freeman WR
    Retina; 2004 Jun; 24(3):376-82. PubMed ID: 15187659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune recovery uveitis.
    Dunn JP
    Hopkins HIV Rep; 2001 Nov; 13(6):9-10. PubMed ID: 11727417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.